Norepinephrine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00368 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 37 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | obstructive lung disease | KG + DL |
| 2 | respiratory malformation | KG + DL |
| 3 | Rienhoff syndrome | KG + DL |
| 4 | transient ischemic attack (disease) | KG + DL |
| 5 | chronic obstructive pulmonary disease | KG + DL |
| 6 | asthma-related traits, susceptibility to | KG + DL |
| 7 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 8 | anaphylaxis | KG + DL |
| 9 | tracheal stenosis | KG + DL |
| 10 | compensatory emphysema | KG + DL |
| 11 | interstitial emphysema | KG + DL |
| 12 | hyperlucent lung | KG + DL |
| 13 | congenital lobar emphysema | KG + DL |
| 14 | massive neonatal aspiration syndrome | KG + DL |
| 15 | cough variant asthma | KG + DL |
| 16 | tracheal calcification | KG + DL |
| 17 | hantavirus infectious disease | KG + DL |
| 18 | headache disorder | KG + DL |
| 19 | meconium aspiration syndrome | KG + DL |
| 20 | trigeminal autonomic cephalalgia | KG + DL |
| 21 | respiratory syncytial virus bronchiolitis | KG + DL |
| 22 | susceptibility to respiratory infections associated with CD8alpha chain mutation | KG + DL |
| 23 | bronchial disease | KG + DL |
| 24 | lung disease | KG + DL |
| 25 | COPD, severe early onset | KG + DL |
| 26 | bronchial neoplasm (disease) | KG + DL |
| 27 | endobronchial leiomyoma | KG + DL |
| 28 | endobronchial lipoma | KG + DL |
| 29 | obsolete rare pulmonary disease | KG + DL |
| 30 | bronchus adenoma | KG + DL |
| 31 | migraine with brainstem aura | KG + DL |
| 32 | laryngotracheitis | KG + DL |
| 33 | migraine disorder | KG + DL |
| 34 | papillary conjunctivitis | KG + DL |
| 35 | tracheal disease | KG + DL |
| 36 | primary hereditary glaucoma | KG + DL |
| 37 | Raynaud disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.